Immune/JJ
hyperactivation/NN
of/IN
HIV-1-infected/JJ
T/NN
cells/NNS
mediated/VBN
by/IN
Tat/NN
and/CC
the/DT
CD28/NN
pathway/NN
./.

Human/JJ
immunodeficiency/NN
virus-type/NN
1/CD
(/(
HIV-1/NN
)/)
infection/NN
is/VBZ
characterized/VBN
by/IN
a/DT
chronic/JJ
state/NN
of/IN
immune/JJ
hyperactivation/NN
in/IN
patients/NNS
./.
=====
Infection/NN
of/IN
human/JJ
peripheral/JJ
blood/NN
lymphocytes/NNS
with/IN
HIV-1/NN
in/FW
vitro/FW
resulted/VBD
in/IN
increased/VBN
interleukin-2/NN
(/(
IL-2/NN
)/)
secretion/NN
in/IN
response/NN
to/TO
T/NN
cell/NN
activation/NN
via/IN
the/DT
CD3/NN
and/CC
CD28/NN
receptors/NNS
./.
=====
Expression/NN
of/IN
the/DT
HIV-1/NN
transactivator/NN
Tat/NN
recapitulated/VBD
this/DT
phenotype/NN
and/CC
was/VBD
associated/VBN
with/IN
increased/VBN
IL-2/NN
secretion/NN
in/IN
response/NN
to/TO
costimulation/NN
with/IN
CD3/NN
plus/CC
CD28/NN
./.
=====
IL-2/NN
superinduction/NN
by/IN
Tat/NN
occurred/VBD
at/IN
the/DT
transcriptional/JJ
level/NN
,/,
was/VBD
mediated/VBN
by/IN
the/DT
CD28-responsive/JJ
element/NN
in/IN
the/DT
IL-2/NN
promoter/NN
,/,
and/CC
was/VBD
exclusively/RB
dependent/JJ
on/IN
the/DT
29/CD
amino/NN
acids/NNS
encoded/VBN
by/IN
the/DT
second/JJ
exon/NN
of/IN
Tat/NN
./.